Press release
Global Antibodies Production Market Shines Amid Growing Prevalence of Serious Diseases
Download Exclusive Sample of this Report: http://bit.ly/2fZfBAn
The primary factor governing the overall growth rate of the global antibodies production market is the growing prevalence of the diseases that can be fought by speeding up the development in this market. Antibody production research and development has attracted many medical personnel and biological scientists due to the immense benefits that this market’s growth can provide to all of the healthcare industry.
Antibodies possess the incredibly valuable property of targeting specific cells. This allows the global antibodies production market to be a highly potential holder of the cure to cancer. This is reflected in the immense research and development in antibody production that is aimed at improving cancer treatments. A majority of the cancer-based research in the global antibodies production market has led to the large-scale production of monoclonal antibodies which can be replicated in laboratories.
Another factor benefitting the global antibodies production market is the growing number of antibody drug conjugates that are currently under clinical trials. The global antibodies production market will, however, continue to be hampered by the high cost of development of antibody production methods and the low number of antibodies that are being made commercially available.
North America holds a dominant share in the global antibodies production market at the moment. This region – especially the U.S. – holds a very high rate of research and innovation in biotechnology and pharmaceuticals through the presence of several globally prominent players from both industries. These companies have consistently been at the forefront of the development cycle in the global antibodies production market and the developments for related therapeutic procedures and drugs. On the other hand, Asia Pacific is showing a strong increase in its demand for antibodies production options due to a heavy demand for cost-effective treatment options for the increasingly prevalent chronic diseases.
The global antibodies production market is usually segmented on the basis of antibody types and their applications. The two key groups of antibodies are monoclonal and polyclonal antibodies. The former includes the sub-segments of murine, chimeric, and humanized antibodies. The applications based on the global antibodies production market include transplantation, hematology/oncology, cardiology, infections, rheumatology, and gastroenterology.
Browse Research Report: http://bit.ly/2fxQwcI
The key players in the global antibodies production market include Merck Millipore, GeneTex, Inc., GE Healthcare, Genentech, Thermo Fisher Scientific, Inc., Abbott Laboratories, Eli Lilly and Company, Sigma-Aldrich Corporation, Abcam plc, and Roche Diagnostics Corporation.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antibodies Production Market Shines Amid Growing Prevalence of Serious Diseases here
News-ID: 380623 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Transparency
transparency market research
The global Custom Antibody Market market is estimated to attain a valuation of US$1 Billion by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.085% during the forecast period, 2023 to 2033.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading…
Transparency Market Research
A belt drive is a type of power transmission device which is a looped belt wound around a pair of pulley so as to transmit power between two or more rotating shafts. Compared to other power transmitting devices, belt drives are more preferred in mechanical industry due to easy installation, numerous speed ratio selections, less power loss and comparative low price. Belt drive protects the rotating machinery from overload fluctuations…
Transparency Market Research
An ultrasonic motor is an electric motor which is driven by the ultrasonic vibration of a component. The stator of the motor is supported by piezoelectric components in ultrasonic frequency range which produces different types of vibrations depending on its arrangement. In other words, ultrasonic motor is a type of electric motor that transforms ultrasonic physical vibrations to linear motion, produced by a piezo-transducer. Ultrasonic motors therefore do not use…
More transparency in Engineering IT
CPO certification helps evaluate openness of IT systems
Digitalization is making openness in the linking of IT solutions increasingly important. The Code of PLM Openness (CPO), developed by the ProSTEP iViP Association, supplies a concrete approach for achieving precisely that. Fraunhofer IAO has now developed an effective certification for companies, which helps them comply with the CPO criteria.
Industrie 4.0 requires intensified collaboration between various tools and systems. Only when…
eDataCenterAnalyzer Increases Transparency in Data Centers
30 June 2016. Walldorf, Germany. – fluid Operations™ AG (fluidOps), a leader in semantic technologies, today launched eDataCenterAnalyzer™, an app that increases transparency in data centers. With the launch of this app and new releases of its Smart Data Platform Information Workbench™ and cloud management app eCloudManager™, the company has set the cornerstone for the future development of its product portfolio.
eDataCenterAnalyzer combines the full functionality of Information Workbench with innovative…
Transparency across the entire process chain
Leitner Spedition implements best4log-x
• Austrian trucking company uses arvato Systems solution
• End-to-end process management provides higher efficiency
(arvato Systems) Gütersloh / Unterpremstätten – Since the beginning of 2015, the Austrian trucking company Leitner Spedition has been working with the best4log-x transport management system. This SAP-based solution from arvato Systems provides an integrated digital information flow and supports mid-sized companies in achieving a transparent process design. Controlling and Reporting have seen a…
